Clinical Trial Update: De-escalation of Neoadjuvant Chemotherapy Regimens With Immunotherapy Among TNBC

View source ↗

Summary

A clinical trial is investigating de-escalation of neoadjuvant chemotherapy regimens combined with immunotherapy for triple-negative breast cancer, and the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Peking University People's Hospital | Conditions: Triple Negative Breast Cancer | Status: RECRUITING